iTonic Holdings Ltd. (ITOC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iTonic Holdings Ltd. (ITOC) has a cash flow conversion efficiency ratio of -0.599x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.84 Million) by net assets ($4.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
iTonic Holdings Ltd. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how iTonic Holdings Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ITOC liabilities breakdown for a breakdown of total debt and financial obligations.
iTonic Holdings Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iTonic Holdings Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apex Resources Inc
V:APX
|
-0.058x |
|
Marna Beteiligungen AG
F:M5S
|
N/A |
|
Vertical Explorations Inc
V:VERT
|
-0.030x |
|
Odyssean Investment Trust PLC
LSE:OIT
|
0.000x |
|
ODI PHARMA AB
F:6OD
|
N/A |
|
BIOMIND LABS INC.
F:3XI
|
0.025x |
|
Coloseum Holding a.s.
PR:COLOS
|
N/A |
|
NextEnergy Solar Fund Ltd
LSE:NESF
|
0.048x |
Annual Cash Flow Conversion Efficiency for iTonic Holdings Ltd. (2021–2025)
The table below shows the annual cash flow conversion efficiency of iTonic Holdings Ltd. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see how much is iTonic Holdings Ltd. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $8.13 Million | $-3.23 Million | -0.398x | -217.33% |
| 2024-12-31 | $6.18 Million | $-775.00K | -0.125x | +39.69% |
| 2023-12-31 | $306.27K | $-63.64K | -0.208x | +0.48% |
| 2022-12-31 | $556.32K | $-116.15K | -0.209x | -346.71% |
| 2021-12-31 | $954.34K | $80.77K | 0.085x | -- |
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment p… Read more